Digipath, Inc. (OTCQB:DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it has appointed Alfredo Axtmayer, M.D. to its Board of Directors.

Dr. Axtmayer is an orthopedic surgeon in Wallingford, Connecticut and is affiliated with multiple hospitals in the area, including Hospital of St. Raphael and MidState Medical Center. Dr. Axtmayer serves as an Associate Professor at the MidState Medical Center Campus Department of Surgery, as a Clinical Instructor in Orthopaedics and Rehabilitation at Yale University School of Medicine, and as an Assistant Clinical Professor in the Yale University School of Medicine's Department of Orthopaedics and Rehabilitation.

He has also authored instructional course lectures on the management and diagnosis of prosthetic joint infections, hip fractures, carpal tunnel syndrome, and medial knee osteoarthritis, and he has written academy guidelines on the management of knee osteoarthritis, low back pain, hip fractures, and rotator cuff disorders.

Dr. Axtmayer received his B.A. from Yale and his M.D. from Yale University School of Medicine.

Joseph Bianco, the CEO of Digipath, commented, "We are honored to add Dr. Alfredo Axtmayer to Digipath's Board of Directors. Dr. Axtmayer's work as a physician and as a Clinical Instructor and Assistant Clinical Professor at the Yale University School of Medicine will bring great expertise and insight to our company. It may also help us establish public-private partnerships with the university community and its constituents in an effort to further develop Digipath's science, data and other intellectual property."

About Digipath, Inc.

Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath's two business units are Digipath Labs and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.

For more information please visit http://www.Digipath.com/